Researchers at the Salk Institute have used CRISPR to uncover hidden microproteins that control fat cell growth and lipid ...

Crispr Therapeutics (($CRSP)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1 Dose ...

By using a protein called Cas9 to find and remove a damaged portion of a genetic sequence and then replace it using a ...

The new programmable chromosome engineering systems can manipulate DNA bases with 3.5 times more efficiency than original enzyme editor.

Crispr Therapeutics AG has experienced a notable stock price decline of 7.70% over the past week, despite recent positive developments. The downturn comes amid a backdrop of signi ...

A large language model can design and troubleshoot CRISPR protocols from scratch, allowing first-time researchers to achieve ...

The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute ...

A team from UC San Diego, John Hopkins and UC Berkeley Universities found a way to edit a single gene in a mosquito that ...

Researchers developed a method to dissect immune-regulatory programs via integrative time-series analysis and high-content CRISPR screening.

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

CRISPR research is advancing at a rapid pace, and it can be hard to keep up. In only seven years, CRISPR went from an evolutionary adaptation in bacteria to a gene-editing tool that created the ...

“Crispr is not the be-all and end-all,” says Dan Voytas of the University of Minnesota, one of the pioneers of agricultural gene editing. Moreover, genomes are complex, even in plants.